Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "european patent office total"

Token, Inc. Launches London Office to Answer Demand from Europ...

Multiple trials and POCs underway with banks seeking to monetise PSD2 via revolutionary new payment rail 02 August 2016 Token, Inc., a new crypto-payment network and API ecosystem that enables European banks to monetise their investment in PSD2, ... PaymentsJournal, 4 weeks ago

30 images for european patent office total

Government of Jamaica, 4 weeks ago, 2 weeks ago
Yahoo! Finance UK and Ireland, 2 weeks ago
SeedQuest, 2 weeks ago
GAO, 1 month ago
Proactive Investors USA, 1 month ago
Forwardgeek, 2 months ago
Financial Buzz, 1 month ago
Floor Daily, 2 months ago, 2 months ago

Vaxil Announces Key US Patent and Trademark Office Notice of Allowance for Its Immunotherapy

) - VAXIL BIO (TSX VENTURE: VXL),a biotechnology company specializing in immunotherapy, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent providing broad coverage over Vaxil's ...
 Digital Journal3 weeks ago Vaxil Announces Key U.S. Patent And Trademark Office Notice Of Allowance For Its Immunotherapy  BioSpace3 weeks ago
Boe Report

Tecogen Announces ULTRATEK To Initiate Phase 2 Development For Breakthrough Emission Control Technology For Gasoline Vehicles

Waltham, MA /PRNewswire/ - Tecogen® Inc. (NASDAQ: TGEN ), a leading provider of clean energy products which, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint, today announced ...
 Pollution Online2 weeks ago Tecogen announces phase 2 of ULTRATEK testing  Energy Global3 weeks ago ULTRATEK to start phase 2 development for Ultera emissions control technology for gasoline vehicles  Automotive Business Review3 weeks ago

Sanofi Q2 Results: Growth Of 2 Newly Launched Drugs, But Uncertainties Still Remain

Sanofi SNY Sanofi (NYSE: SNY ) is a European pharmaceutical company, which is fourth in the top 10 pharma companies of the world. The company carries out research, development and marketing of pharmacological products from three main segments: ...
 Seeking Alpha2 weeks ago

Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results

Total Revenues of $186.5 Million Adjusted EPS of $0.36 and Diluted EPS of $0.32 Company Issues Fiscal First-Quarter 2017 and Fiscal Year 2017 Financial Guidance SALT LAKE CITY, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: ...
 Benzinga.com3 weeks ago

UK Card Fraud Losses Climbed 18 Percent in 2015, Largest Rise in Europe

Fair Isaac Corproation (NYSE:FICO) Intraday Stock Chart Today : Thursday 4 August 2016 Interactive map from FICO and Euromonitor International shows card fraud rose in 10 of 19 European countries last year LONDON , Aug. 4, 2016 ...
 ADVFN India3 weeks ago FAIR ISAAC : UK Card Fraud Losses Climbed 18 Percent in 2015, Largest Rise in Europe  4 Traders3 weeks ago

234 startups from 25 European countries are in the running for EIT Digital Challenge 2016

234 startups from 25 countries now competing in the EIT Digital Challenge (PRWEB UK) 3 August 2016 234 entrepreneurs from 25 countries submitted applications to the EIT Digital Challenge in order to compete in Europe's most prestigious ...
 PRWeb4 weeks ago

Patents: Problem or Panacea

The cost for hepatitis C treatment has understandably caused alarm. However it is the exclusivity provided by patents that allow Gilead such control over the price of the medication. There are potentially up to 12 patents relating to sofosbuvir(1).
 British Medical Journal4 weeks ago

Chimerix Announces Second Quarter 2016 Financial Results

- European Commission Granted Orphan Drug Designation for Brincidofovir for the Treatment of Adenovirus - - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Chimerix ( CMRX ), a biopharmaceutical company ...
 Yahoo! Singapore3 weeks ago Aegerion Pharmaceuticals Announces Second Quarter 2016 Financial Results  Pharmacy Choice3 weeks ago Syros Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update  PharmaVOICE2 weeks ago SYROS PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results and Provides Business Update  4 Traders2 weeks ago

Price wars: why Pfizer should not get the pneumonia vaccine patent

On 29 July, Doctors Without Borders or Médecins Sans Frontières (MSF) bid against US-based pharmaceutical company Pfizer in a patent hearing case. If granted, the patent that could potentially stall the manufacturing of a generic version of a pneumonia ...
 catchnews.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - european patent office total
Get updated on latest news & your favorite topics right in your inbox!
More     Less